Redsense Medical AB (publ) (XSAT:REDS)
Sweden · Delayed Price · Currency is SEK 4.280
+0.110 (2.64%)
At close: Feb 4, 2026
Redsense Medical AB Company Description
Redsense Medical AB (publ) develops a monitoring system to detect sign of a blood leak using patented fiber optic technology primarily in Europe, Canada, and the United States.
The company offers Redsense System, a product that is used for monitoring and alarming in the case of blood leakage during hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an optic fiber and an absorbent sponge-like material.
It also provides Redsense Clamp, an accessory to the alarm unit which enables the automatic stop of the flow in the blood line in case of an incident, regardless of the type of dialysis machine.
Redsense Medical AB (publ) was founded in 2000 and is based in Halmstad, Sweden.
Redsense Medical AB (publ)
| Country | Sweden |
| Founded | 2000 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 4 |
| CEO | Sebastien Bollue |
Contact Details
Address: Storgatan 36 Halmstad, 302 43 Sweden | |
| Phone | 46 35 10 60 30 |
| Website | redsensemedical.com |
Stock Details
| Ticker Symbol | REDS |
| Exchange | Spotlight Stock Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Sebastien Bollue | Chief Executive Officer |
| Peter Larsson | Chief Financial Officer |